Yuichiro Nagano - Publications

Progression from normal vessel wall to atherosclerotic plaque: lessons from an optical coherence tomography study with follow-up of over 5 years.

Journal: Heart and vessels

Published: January 12, 2021

Medial frontal negativities predict performance improvements during motor sequence but not motor adaptation learning.

Journal: Psychophysiology

Published: March 22, 2020

Imbalance Between Salivary Cortisol and DHEA Responses Is Associated with Social Cost and Self-perception to Social Evaluative Threat in Japanese Healthy Young Adults.

Journal: International journal of behavioral medicine

Published: December 21, 2019

Wall Shear Stress and Plaque Vulnerability: Computational Fluid Dynamics Analysis Derived From cCTA and OCT.

Journal: JACC. Cardiovascular imaging

Published: September 24, 2019

Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report.

Journal: JACC. Cardiovascular imaging

Published: August 23, 2019

Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 24, 2019

Impaired Cholesterol-Uptake Capacity of HDL Might Promote Target-Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation.

Journal: Journal of the American Heart Association

Published: April 19, 2019

Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: An optical coherence tomography-based observational study.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: October 20, 2018

Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.

Journal: Journal of cardiology

Published: October 03, 2018

Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents.

Journal: Heart and vessels

Published: September 20, 2018

Peri-strut low-intensity area assessed by midterm follow-up optical coherence tomography may predict target lesion revascularisation after everolimus-eluting stent implantation.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: June 30, 2018

Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease.

Journal: Data in brief

Published: January 22, 2018